Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Seruca

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of Medical Genetics|September 3, 2004
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingE Domingo, P Laiho, M Ollikainen, et al.
Virchows Archiv : an International Journal of Pathology|September 20, 2008
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance programJ H J M van Krieken, A Jung, T Kirchner, et al.
Journal of Medical Genetics|April 16, 2005
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancerT Frebourg, C Oliveira, P Hochain, et al.
Journal of Medical Genetics|December 14, 1999
Familial gastric cancer: overview and guidelines for managementC Caldas, F Carneiro, H T Lynch, et al.
Oncogene|July 5, 2006
High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instabilityV Davalos, H Dopeso, S Velho, et al.
Journal of Medical Genetics|July 6, 2004
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteriaA R Brooks-Wilson, P Kaurah, G Suriano, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of Medical Genetics|September 3, 2004
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingE Domingo, P Laiho, M Ollikainen, et al.
Virchows Archiv : an International Journal of Pathology|September 20, 2008
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance programJ H J M van Krieken, A Jung, T Kirchner, et al.
Journal of Medical Genetics|April 16, 2005
Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancerT Frebourg, C Oliveira, P Hochain, et al.
Journal of Medical Genetics|December 14, 1999
Familial gastric cancer: overview and guidelines for managementC Caldas, F Carneiro, H T Lynch, et al.
Oncogene|July 5, 2006
High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instabilityV Davalos, H Dopeso, S Velho, et al.
Journal of Medical Genetics|July 6, 2004
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteriaA R Brooks-Wilson, P Kaurah, G Suriano, et al.
Pageof 9